申请人:HOFFMANN-LA ROCHE INC.
公开号:US20150376165A1
公开(公告)日:2015-12-31
The present invention discloses compounds of Formula I wherein the variables in Formula I are defined as described herein. Also disclosed are pharmaceutical compositions containing such compounds and methods for using the compounds of Formula I in the prevention or treatment of HCV infection.
本发明揭示了式I化合物,其中式I中的变量如本文所述。还揭示了包含这样的化合物的制药组合物以及使用式I化合物预防或治疗HCV感染的方法。